Pharmaceutical Companies Racing For A COVID-19 Vaccine

We expect the development efforts to intensify in the coming weeks and expect more companies entering the clinical trial Phase I, where the vaccine is tested in a small sample of healthy humans with moderate doses.

We also anticipate more companies advancing to Clinical Trial Phase II, where a larger sample of subjects of different age groups are tested for safety, efficiency, and determining the right dosing, and move to Clinical Phase III rapidly, where more complex and rigorous tests are performed on a much broader population.

More Here

MoneyShow Contributor